EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Feasibility of anticoagulation-free peripheral veno-arterial extracorporeal membrane oxygenation in re-do lung transplantation

Chitaru Kurihara, Yudai Miyashita, Taisuke Kaiho, Dai Yamanouchi

Journal of Artificial Organs · 2026

DOI: 10.1007/s10047-025-01541-8 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Artificial Organs, 2026. Verfasst von Chitaru Kurihara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA. chitaru.kurihara@…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Lung Transplantation, Reoperation, Intraoperative Care. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate the feasibility and safety of anticoagulation-free peripheral veno-arterial extracorporeal membrane oxygenation (VA-ECMO) during lung re-transplantation and to assess its impact on blood transfusion requirements and clinical outcomes.

Methods

In this single-center retrospective cohort (January 2023–April 2025), we included adults undergoing bilateral re-do lung transplantation on peripheral VA-ECMO with an anticoagulation-avoidance protocol; primary lung transplants were not included. Data on patient demographics, intraoperative transfusion volumes, postoperative complications, and survival were collected. The primary outcomes were intraoperative packed red blood cell transfusion volume and overall survival; secondary outcomes included incidence of primary graft dysfunction, acute kidney injury, and hemorrhagic and thromboembolic events. Continuous variables are reported as medians with interquartile ranges, and survival was estimated using the Kaplan–Meier method.

Results

Seven patients (median age, 42 years; range, 30–56 years) underwent re-transplantation for chronic lung allograft dysfunction. The median intraoperative transfusion requirement was 560 ml (interquartile range 280–1050 ml). One patient developed primary graft dysfunction of grade 3and two developed stage 3 acute kidney injury requiring renal replacement therapy. Two developed deep venous thrombosis nonrelated to ECMO cannulation; no pulmonary embolism occurred. At a median follow-up of 469 days, all patients survived without evidence of recurrence of chronic lung allograft dysfunction.

Conclusions

Full anticoagulation-free peripheral VA-ECMO during lung re-transplantation is feasible and safe, with acceptable complication rates and potential reduction in transfusion requirements. Larger, multicenter studies are warranted to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationLung TransplantationReoperationIntraoperative CareFeasibility StudiesRetrospective StudiesFollow-Up StudiesPostoperative ComplicationsErythrocyte TransfusionPrimary Graft DysfunctionHumansMaleFemaleAdultMiddle AgedAged

Stichwörter der Autor:innen

Blood transfusion requirementHeparin-free extracorporeal membrane oxygenationLung retransplantationPeripheral venoarterial ECMOPrimary graft dysfunction

Autor:innen und Institutionen

  • Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA. chitaru.kurihara@northwestern.edu.
  • Department of Vascular Surgery, Fujita Health University, Toyooke, Japan. chitaru.kurihara@northwestern.edu.
  • Division of Thoracic Surgery, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair St., Suite 650, Chicago, IL, 60611, USA. chitaru.kurihara@northwestern.edu.
  • Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA. miyasea1225@gmail.com.
  • Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair St., Suite 650, Chicago, IL, 60611, USA. miyasea1225@gmail.com.
  • Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA.

Zitieren

APA

Kurihara, C., Miyashita, Y., Kaiho, T., & Yamanouchi, D. (2026). Feasibility of anticoagulation-free peripheral veno-arterial extracorporeal membrane oxygenation in re-do lung transplantation. Journal of Artificial Organs. https://doi.org/10.1007/s10047-025-01541-8

Vancouver

Kurihara C, Miyashita Y, Kaiho T, Yamanouchi D. Feasibility of anticoagulation-free peripheral veno-arterial extracorporeal membrane oxygenation in re-do lung transplantation. Journal of Artificial Organs. 2026. doi:10.1007/s10047-025-01541-8

BibTeX
@article{Kurihara2026,
  author = {Kurihara, Chitaru and Miyashita, Yudai and Kaiho, Taisuke and Yamanouchi, Dai},
  title = {Feasibility of anticoagulation-free peripheral veno-arterial extracorporeal membrane oxygenation in re-do lung transplantation},
  journal = {Journal of Artificial Organs},
  year = {2026},
  doi = {10.1007/s10047-025-01541-8}
}
Kostenlos starten →